Skip to main content
ARTELO BIOSCIENCES, INC. logo

ARTELO BIOSCIENCES, INC. — Investor Relations & Filings

Ticker · ARTL ISIN · US04301G7060 US Manufacturing
Open in API
Filings indexed 425 across all filing types
Latest filing 2018-10-02 Major Shareholding Noti…
Country US United States of America
Listing US ARTL

About ARTELO BIOSCIENCES, INC.

https://artelobio.com/

Artelo Biosciences, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapeutics. The company's scientific approach is centered on modifying lipid-signaling pathways, particularly by modulating the endocannabinoid system. Its primary therapeutic focus is on developing improved treatments for patients with cancer and other serious diseases. Artelo is advancing a diverse portfolio of drug candidates through its development pipeline to address unmet medical needs.

Recent filings

Filing Released Lang Actions
SC 13G
Major Shareholding Notification
2018-10-02 English
FORM S-1
Capital/Financing Update Classification · 95% confidence The document is a Form S-1 Registration Statement filed with the SEC, which is used by companies to register securities for public offering under the Securities Act of 1933. It includes detailed information about the company, the securities being offered, risk factors, use of proceeds, management discussion, and other disclosures typical of a registration statement prospectus. This is not an annual report, earnings release, or any other financial report type. It is a capital markets filing related to the company's initial or additional public offering of securities. According to the filing definitions, updates on company fundraising or financing activities fall under Capital/Financing Update (CAP). Therefore, this document should be classified as a Capital/Financing Update (CAP). The document length and content confirm it is the actual registration statement, not just an announcement or a certification, so it is not RPA or RNS. Confidence is high given the clear identification as Form S-1 Registration Statement.
2018-09-27 English
FORM 8-K
Capital/Financing Update Classification · 100% confidence The document is a Form 8-K current report filed with the SEC, dated September 12, 2018. It details the entry into a material definitive agreement involving a private placement offering of equity securities, including subscription agreements and registration rights. The content focuses on financing activities, specifically the issuance of units consisting of common stock and warrants, and the proceeds from this offering. There are no financial statements or comprehensive financial performance data included, nor is it an announcement of a report publication. The primary subject is a capital raising event and related agreements, which fits the Capital/Financing Update category.
2018-09-14 English
Regulatory Filings 2018
Regulatory Filings
2018-09-14 English
424B3
Interim / Quarterly Report Classification · 100% confidence The document is a Form 10-Q Quarterly Report filed with the SEC for the quarterly period ended May 31, 2018. It contains detailed unaudited financial statements including balance sheets, statements of operations, cash flows, and notes to the financial statements. The document also includes management's discussion and analysis, risk factors, legal proceedings, and other required disclosures typical of a quarterly report. The presence of actual financial data and comprehensive financial information confirms this is a full interim/quarterly report rather than a brief announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2018-07-27 English
FORM 10-Q
Interim / Quarterly Report Q3 2018
2018-07-13 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.